Our passion is transforming the data we collect into engaging insights.
We are a global provider of industry leading healthcare and pharmaceutical market research solutions backed by our Leave No Stone Unturned Guarantee.
A market research panel exclusively for healthcare professionals.
Industry Expertise
Since 2003, we have conducted market research in a variety of health-related areas amassing deep expertise and proprietary norms within the pharmaceutical and healthcare industry.
Superior Sample
Fueled by our proprietary market research panel of healthcare professionals, our in-house field team consistently delivers more target respondents and larger sample sizes.
Engaging Insights
Recognized in the health and pharmaceutical market research industry for our visually intuitive and engaging story-based reports, we move the boardroom conversation from understanding to taking action.
A market research panel exclusively for healthcare professionals.
Topical Polls and Industry Trends
In-person Interactions With Pharma Will Return
While the vaccination campaign in the U.S. is progressing, COVID-19 continues to significantly impact healthcare practices. As knowledge about the virus evolved during the pandemic, physicians and other HCPs have continuously adapted how they manage their patients and how they interact with key stakeholders. Half of the physicians surveyed expect to see increased workloads as 2021 draws to a close. Patient volumes continue to inch closer to pre-pandemic levels and requests for diagnostic testing along with treatment switches have now exceeded pre-pandemic levels.
MD Analytics has been monitoring these trends and we are excited to share with you our new downloadable infographic on this topic.
Virtual Interactions With Pharma Are Here To Stay
While the vaccination campaign in Canada has shown positive progress, the COVID-19 pandemic continues to significantly impact the way in which HCPs interact with both patients and pharma. MD Analytics has been monitoring these trends over the past year and we are excited to share with you our 4th wave infographic on this topic.
For the first time since initiating this tracking study, patient volumes have returned back to pre-pandemic conditions, as have key measures such are diagnostic tests performed and treatment switches. It is important to note that while most physicians feel that their workloads are now similar to pre-COVID conditions, many expect to exceed their current levels in the coming months.
COVID-19 Impact on Women in Pharma
The COVID-19 crisis changed the way people work across industries including the pharma industry. MD Analytics teamed up with the professional association for women in the pharma industry Women Leaders in Pharma to conduct a study on the impact on of COVID-19 on women who work in the pharma industry.
Your answers,
our guarantee.